Literature DB >> 27672051

Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.

Tsubasa Hiraki1, Sohsuke Yamada2, Michiyo Higashi1, Kazuhito Hatanaka1, Seiya Yokoyama1, Ikumi Kitazono1, Yuko Goto1, Mari Kirishima1, Surinder K Batra3,4, Suguru Yonezawa1, Akihide Tanimoto1.   

Abstract

Mucins play pivotal roles in influencing cancer biology, for example affecting carcinoma invasion, aggressiveness and/or metastatic potential. Our aim is to investigate the significance of expression profiles of two mucins in particular, MUC1 and MUC2, their correlations with various clinicopathological features, and prognosis in gallbladder adenocarcinoma (GBAC). We performed immunohistochemistry from patients with surgically resected GBAC, using antibodies against mucin core proteins MUC1/DF3 and MUC2/Ccp58 in 81 paraffin-embedded tumor samples. MUC1 or MUC2 expression was considered to be high when ≥ 20% or 10% of the GBAC cells showed positive staining, respectively. High MUC1 expression was revealed to have a significant relationship to the presence of pathologically lymphatic and vascular invasion, and regional lymph node metastasis. By contrast, high MUC2 expression showed a significant correlation with pathologically perineural invasion, T stage ≥ 3, and post-operative recurrence. Moreover, MUC1 showed significantly positive co-expression and potentially complementary correlations with MUC2. Multivariate analyses demonstrated that the high MUC1 expression group had significantly shorter disease-specific survival times. However, the combination of both high MUC1 and MUC2 expression did not predict worse outcome in GBACs. Therefore, although each mucin has a somewhat important role in the pathogenesis of GBAC progression, MUC1 can independently predict vessel invasion and poor prognosis in patients with GBAC. The detection of MUC1 might well offer a useful parameter for providing clinical management and treatment against postsurgical GBACs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27672051     DOI: 10.14670/HH-11-824

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

Review 1.  Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Chao Li; Didi Zuo; Libin Yin; Yuyang Lin; Chenguang Li; Tao Liu; Lei Wang
Journal:  Gastroenterol Res Pract       Date:  2018-06-05       Impact factor: 2.260

Review 2.  Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Chao Li; Didi Zuo; Tao Liu; Libin Yin; Chenyao Li; Lei Wang
Journal:  Gastroenterol Res Pract       Date:  2019-12-20       Impact factor: 2.260

3.  PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland.

Authors:  Takuya Yoshimura; Shotaro Higashi; Sohsuke Yamada; Hirotsugu Noguchi; Mitsuharu Nomoto; Hajime Suzuki; Takayuki Ishida; Hirotaka Takayama; Yuka Hirano; Masaru Yamashita; Akihide Tanimoto; Norifumi Nakamura
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

4.  The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.

Authors:  Akihiro Shioya; Xin Guo; Nozomu Motono; Seiya Mizuguchi; Nozomu Kurose; Satoko Nakada; Akane Aikawa; Yoshitaka Ikeda; Hidetaka Uramoto; Sohsuke Yamada
Journal:  Int J Med Sci       Date:  2018-06-14       Impact factor: 3.738

5.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

6.  Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.

Authors:  Yan Yao; Tingting Zhang; Lingyu Qi; Ruijuan Liu; Gongxi Liu; Jia Wang; Qi Song; Changgang Sun
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.